Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

213 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Lipid-lowering in diabetes: An update.
Chait A, Eckel RH, Vrablik M, Zambon A. Chait A, et al. Among authors: vrablik m. Atherosclerosis. 2024 Jul;394:117313. doi: 10.1016/j.atherosclerosis.2023.117313. Epub 2023 Oct 6. Atherosclerosis. 2024. PMID: 37945448 Free article. Review.
Bempedoic acid in the management of lipid disorders and cardiovascular risk. 2023 position paper of the International Lipid Expert Panel (ILEP).
Banach M, Penson PE, Farnier M, Fras Z, Latkovskis G, Laufs U, Paneni F, Parini P, Pirro M, Reiner Ž, Vrablik M, Escobar C. Banach M, et al. Among authors: vrablik m. Prog Cardiovasc Dis. 2023 Jul-Aug;79:2-11. doi: 10.1016/j.pcad.2023.03.001. Epub 2023 Mar 7. Prog Cardiovasc Dis. 2023. PMID: 36889490 Free article. Review.
A Phase 3 Randomized Controlled Trial to Evaluate Efficacy and Safety of New-Formulation Zenon (Rosuvastatin/Ezetimibe Fixed-Dose Combination) in Primary Hypercholesterolemia Inadequately Controlled by Statins.
Catapano AL, Vrablik M, Karpov Y, Berthou B, Loy M, Baccara-Dinet M. Catapano AL, et al. Among authors: vrablik m. J Cardiovasc Pharmacol Ther. 2022 Jan-Dec;27:10742484221138284. doi: 10.1177/10742484221138284. J Cardiovasc Pharmacol Ther. 2022. PMID: 36420979 Free article. Clinical Trial.
2024 Recommendations on the Optimal Use of Lipid-Lowering Therapy in Established Atherosclerotic Cardiovascular Disease and Following Acute Coronary Syndromes: A Position Paper of the International Lipid Expert Panel (ILEP).
Banach M, Reiner Ž, Surma S, Bajraktari G, Bielecka-Dabrowa A, Bunc M, Bytyçi I, Ceska R, Cicero AFG, Dudek D, Dyrbuś K, Fedacko J, Fras Z, Gaita D, Gavish D, Gierlotka M, Gil R, Gouni-Berthold I, Jankowski P, Járai Z, Jóźwiak J, Katsiki N, Latkovskis G, Magda SL, Margetic E, Margoczy R, Mitchenko O, Durak-Nalbantic A, Ostadal P, Paragh G, Petrulioniene Z, Paneni F, Pećin I, Pella D, Postadzhiyan A, Stoian AP, Trbusic M, Udroiu CA, Viigimaa M, Vinereanu D, Vlachopoulos C, Vrablik M, Vulic D, Penson PE; International Lipid Expert Panel (ILEP). Banach M, et al. Among authors: vrablik m. Drugs. 2024 Nov 4. doi: 10.1007/s40265-024-02105-5. Online ahead of print. Drugs. 2024. PMID: 39497020 Review.
Association of BMI, lipid-lowering medication, and age with prevalence of type 2 diabetes in adults with heterozygous familial hypercholesterolaemia: a worldwide cross-sectional study.
European Atherosclerosis Society Familial Hypercholesterolaemia Studies Collaboration (EAS FHSC). European Atherosclerosis Society Familial Hypercholesterolaemia Studies Collaboration (EAS FHSC). Lancet Diabetes Endocrinol. 2024 Nov;12(11):811-823. doi: 10.1016/S2213-8587(24)00221-3. Epub 2024 Oct 4. Lancet Diabetes Endocrinol. 2024. PMID: 39374602 Free article.
Lipid measures are associated with cognitive functioning in multiple sclerosis patients.
Lőrincz B, Motýl J, Friedová L, Hrych D, Kubala Havrdová E, Krásenský J, Urban T, Kober T, Maréchal B, Vaněčková M, Horákova D, Vrablik M, Uher T. Lőrincz B, et al. Among authors: vrablik m. Mult Scler Relat Disord. 2024 Nov;91:105879. doi: 10.1016/j.msard.2024.105879. Epub 2024 Sep 6. Mult Scler Relat Disord. 2024. PMID: 39270535 Free article.
213 results